Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Brachytherapy × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 12 Neoplasms 4 Breast Neoplasms 3 Vaginal Neoplasms 2 Uterine Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vulvar Neoplasms 1 Stage IA Uterine Sarcoma 1 Radiation Injuries 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡